Filing Flows › Fulgent Genetics (FLGT) › Free cash flow
Fulgent Genetics (FLGT) free cash flow by quarter
Fulgent Genetics' free cash flow was $107M in Q3 2026 (third quarter 2026), up 57-fold from Q1 2026. Over the last 3 quarters it ranged from $1.9M (Q1 2026) to $107M (Q3 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $107M | 57× | 21× |
| Q1 2026 | $1.9M | -63% | — |
| Q3 2025 | $5.1M | — | — |
Q3 2026 at a glance
Fulgent Genetics, Q3 2026: revenue $90.4M (+8% year over year), operating margin -24.9%, net loss $13.3M, operating cash flow $109M. The chart follows the revenue to costs, profit and cash.
Questions
What is Fulgent Genetics' free cash flow?
Fulgent Genetics' free cash flow was $107M in Q3 2026 (third quarter 2026), up 57-fold from Q1 2026.
How has Fulgent Genetics' free cash flow changed?
Over the last 3 quarters it ranged from $1.9M (Q1 2026) to $107M (Q3 2026).